Exclusive weekly insights for sharemarket success.
Tim Lincoln, Co-Founder and Chief Investment Officer, and Matt Swartz, Senior Portfolio Manager, will join the conversation once a month to share their passion and strategy for Lincoln Indicator’s Managed Funds, as well as their insights for investors.
In this edition of Taking Stock, Managing Director, Tim Lincoln, and Head of Research, Kien Trinh, review the month of October and explain the importance of separating the facts from the noise.
Companies covered this week include ANZ Bank (ANZ), Perpetual (PPT), Resmed (RMD), and Macquarie Group (MQG).
The question of the week touches on how Stock Doctor can help investors identify zombie companies.
We hope you enjoy the episode.
Experience Stock Doctor yourself by taking a FREE trial today.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln representative.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln financial expert.